Cytokine responses to human immunodeficiency virus type I (HIV-1) induced by immunization with live recombinant canarypox virus vaccine expressing HIV-1 genes boosted by HIV-1SF-2 recombinant GP120

被引:11
|
作者
Gorse, GJ
Patel, GB
Mandava, MD
Arbuckle, JA
Doyle, TM
Belshe, RB
机构
[1] St Louis Univ, Sch Med, St Louis Dept Vet Affairs Med Ctr, St Louis, MO 63110 USA
[2] St Louis Univ, Sch Med, Div Infect Dis & Immunol, St Louis, MO 63110 USA
关键词
cell-mediated immunity; HIV-1; cytokines; vaccines;
D O I
10.1016/S0264-410X(00)00378-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Vaccine-induced T-cell memory for human immunodeficiency virus type 1 (HIV-1) was assessed by measuring HIV-1 antigen-stimulated cytokine secretion in 72 HIV-1-uninfected subjects, of whom 52 received live recombinant canarypox virus vaccine expressing HIV-1 env, gag, and protease gene products (vCP205) with or without HIV-1(SF-2) recombinant gp120 (SF-2 rgp120) subunit vaccine, and 20 the control. The vCP205 vaccine induced secretion of the Th1 cytokine, interferon-gamma, by peripheral blood mononuclear cells (PBMC) after in vitro stimulation with HIV-1 p24 and envelope glycoprotein. Immunization schedules with both vCP205 and SF-2 rgp120 subunit vaccines induced secretion of Th1 and Th2 cytokines by PBMC to HIV-1 envelope glycoprotein. Hence, vCP205 and SF-2 rgp170 subunit vaccines given together and in a prime-boost sequence appeared to induce a broader cytokine response pattern than vCP205 vaccine given alone. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1806 / 1819
页数:14
相关论文
共 50 条
  • [41] Evidence that indomethacin prevents apoptosis induced by human immunodeficiency virus type 1 (HIV-1) coat protein gp120 in the neocortex of the rat
    Bagetta, G
    Corasaniti, MT
    Paoletti, AM
    Berliocchi, L
    Costa, N
    Finazzi-Agrò, A
    Nisticò, G
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 123 : U109 - U109
  • [42] SERUM ANTIBODIES TO HIV-1 IN RECOMBINANT VACCINIA VIRUS RECIPIENTS BOOSTED WITH PURIFIED RECOMBINANT GP160
    MONTEFIORI, DC
    GRAHAM, BS
    KLIKS, S
    WRIGHT, PF
    JOURNAL OF CLINICAL IMMUNOLOGY, 1992, 12 (06) : 429 - 439
  • [43] HIV-1 gp120: A Target for Therapeutics and Vaccine Design
    Cicala, Claudia
    Nawaz, Fatima
    Jelicic, Katija
    Arthos, James
    Fauci, Anthony S.
    CURRENT DRUG TARGETS, 2016, 17 (01) : 122 - 135
  • [44] Hyperglycosylated mutants of human immunodeficiency virus (HIV) type 1 monomeric gp120 as novel antigens for HIV vaccine design
    Pantophlet, R
    Wilson, IA
    Burton, DR
    JOURNAL OF VIROLOGY, 2003, 77 (10) : 5889 - 5901
  • [45] AN O-LINKED CARBOHYDRATE NEUTRALIZATION EPITOPE OF HIV-1 GP 120 IS EXPRESSED BY HIV-1 ENV GENE RECOMBINANT VACCINIA VIRUS
    HANSEN, JES
    CLAUSEN, H
    HU, SL
    NIELSEN, JO
    OLOFSSON, S
    ARCHIVES OF VIROLOGY, 1992, 126 (1-4) : 11 - 20
  • [46] Potential of recombinant Mycobacterium paragordonae expressing HIV-1 Gag as a prime vaccine for HIV-1 infection
    Byoung-Jun Kim
    Bo-Ram Kim
    Yoon-Hoh Kook
    Bum-Joon Kim
    Scientific Reports, 9
  • [47] Mass spectrometry-based characterization of recombinant human immunodeficiency virus type 1 (HIV-1) envelope (Env) vaccine
    Sharma, Vaneet
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [48] Potential of recombinant Mycobacterium paragordonae expressing HIV-1 Gag as a prime vaccine for HIV-1 infection
    Kim, Byoung-Jun
    Kim, Bo-Ram
    Kook, Yoon-Hoh
    Kim, Bum-Joon
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [49] DNA inoculations with HIV-1 recombinant genomes that express cytokine genes enhance HIV-1 specific immune responses
    Lee, AH
    Suh, YS
    Sung, YC
    VACCINE, 1999, 17 (05) : 473 - 479
  • [50] Immunogenicity of constrained monoclonal antibody A32-human immunodeficiency virus (HIV) env gp120 complexes compared to that of recombinant HIV type 1 gp120 envelope glycoproteins
    Liao, HX
    Alam, SM
    Mascola, JR
    Robinson, J
    Ma, BJ
    Montefiori, DC
    Rhein, M
    Sutherland, LL
    Scearce, R
    Haynes, BF
    JOURNAL OF VIROLOGY, 2004, 78 (10) : 5270 - 5278